Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 0.1 | 0.1 | 0.1 | 70.4 | 64.9 | 34.7 | 0.2 | 0.0 |
| Revenue growth | 0.0% | 0.0% | -99.9% | 8.5% | 87.0% | 18056.0% | | -100.0% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.1 | 0.1 | 0.1 | 70.4 | 64.9 | 34.7 | 0.2 | 0.0 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Research and development | 25.9 | 27.5 | 26.3 | 41.6 | 57.9 | 35.7 | 28.8 | 14.6 |
| General and administrative | 13.8 | 17.3 | 15.7 | 23.7 | 25.3 | 15.1 | 10.0 | 6.0 |
| EBIT | -56.1 | -44.7 | -42.0 | 5.0 | -18.3 | -16.0 | -38.6 | -20.6 |
| EBIT margin | -80151.5% | -63886.2% | -59961.3% | 7.1% | -28.3% | -46.3% | -20226.2% | |
| Pre-tax income | -55.1 | -43.9 | -41.3 | 5.5 | -18.0 | -17.3 | -40.5 | -20.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -55.1 | -43.9 | -41.3 | 5.5 | -18.0 | -17.3 | -40.5 | -20.1 |
| Net margin | -78663.1% | -62696.5% | -58956.8% | 7.8% | -27.8% | -49.9% | -21218.2% | |
| |
| Diluted EPS | ($1.25) | ($1.04) | ($0.98) | $0.13 | ($0.50) | ($0.48) | ($1.40) | ($21.77) |
| Shares outstanding (diluted) | 43.9 | 42.2 | 41.9 | 41.8 | 36.0 | 35.9 | 29.0 | 0.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|